Dyadic International receives FDA approval for cellulase enzyme
Dyadic International Inc has received approval from the FDA for the use of its C1-derived cellulase enzyme. The enzyme is derived from a genetically modified strain of its patented C1 organism and is used in the fermentation of wine, beer and fruit juices. The approval is known as a “GRAS,” which acknowledges that the product is safe to use in its intended conditions of use.
- Eurand Receives FDA Approval for Zenpep
- Arzerra receives FDA approval
- Eurand receives exclusive license for Chiesi Corticosteroid GI product
- BioCurex obtains patent for therapeutic application of RECAF marker
